new contract signed, page-11

Supertramp; I had asked Guy Drummund at the AGM. He is the director that closed the deal. The BMS (Johnson Mead)contract is a supply agreement for all of BMS Omega 3 DHA needs across their entire products worldwide. (BMS did not want to be at the mercy of one supplier hence the 50%). CLV were actually supplying product to BMS prior to the last signature (it required 7 signatures on the contract from BMS ) .This is the same contract which was announced today. To answer your question all the directors would say that it is significant and that the full impact would be known during 2008. The excitement was the global impact of the deal which at present is unknown but expected to be a large recurring revenue stream